CHINA PHARMA HOLDINGS, INC. Cash Flow Statement
CPHI|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
CHINA PHARMA HOLDINGS, INC. generated $148,261 in operating cash flow and $88,937 in free cash flow in FY2025. Free cash flow margin was 2.1% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.2M | -$3.1M | -$3.1M | -$4.0M | -$2.9M | -$20.7M | -$10.8M | -$19.3M | -$9.2M | -$15.4M | -$39.6M | -$20.0M | $4.6M | $19.3M | $23.4M |
| Depreciation & Amortization | $1.5M | $2.8M | $2.8M | $2.7M | $2.7M | $2.9M | $3.3M | $3.3M | $3.1M | $3.6M | $1.8M | $1.6M | $1.5M | $1.2M | $1.5M |
| Operating Cash Flow | $148.3K | -$699.7K | -$699.7K | -$409.5K | -$42.3K | $608.3K | $1.9M | $841.2K | $2.9M | $3.4M | $6.2M | $8.6M | $3.6M | $5.2M | $7.8M |
| Capital Expenditures | $59.3K | $11.5K | $11.5K | $402.0K | $867.3K | $136.0K | $51.1K | $136.5K | $193.4K | -$685.3K | $5.1M | -$18.8M | -$156.9K | -$352.4K | -$63.9K |
| Free Cash Flow | $88.9K | -$711.2K | -$711.2K | -$811.5K | -$909.6K | $472.3K | $1.8M | $704.7K | $2.7M | $4.0M | $1.0M | $27.4M | $3.8M | $5.6M | $7.8M |
| FCF Margin | 2.1% | -10.1% | -10.1% | -10.0% | -8.4% | 4.3% | 14.8% | 5.3% | 17.4% | 19.8% | 4.6% | 83.5% | 7.0% | 6.9% | 10.5% |